查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2004752

固定式和可攜式C型臂市場：便攜性、應用、最終用戶和銷售管道分類－2026-2032年全球市場預測

Fixed & Mobile C-arms Market by Mobility, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，固定式和移動式 C 型臂市場價值將達到 29.2 億美元，到 2026 年將成長到 31.2 億美元，到 2032 年將達到 44.2 億美元，複合年成長率為 6.07%。

主要市場統計數據
基準年 2025 29.2億美元
預計年份：2026年 31.2億美元
預測年份 2032 44.2億美元
複合年成長率 (%) 6.07%

一個全面的框架，用於說明成像性能、移動特性和互通性要求如何重新定義臨床環境中的採購和部署選擇。

固定式和移動式C臂系統在現代外科手術中繼續發揮核心作用，可在廣泛的外科和介入領域實現即時影像診斷。本報告從技術整合、臨床應用多樣化和採購行為變化觀點分析了市場。隨著醫療系統優先發展微創手術，影像導引平台已成為臨床路徑中不可或缺的一部分，臨床醫生和採購委員會目前正在從解析度、劑量管理、工作流程整合和易用性等方面評估C臂的性能。

人工智慧影像處理、模組化設計以及醫療服務場所的轉變如何重塑 C 型臂系統的採購重點和競爭地位。

C型臂系統的市場環境正經歷變革性的轉變，這主要得益於技術進步、臨床路徑的演進以及醫療服務體系的結構性轉變。人工智慧和先進的影像處理演算法正在改善術中可視化效果，使臨床醫生能夠更精準地進行手術，並有望縮短透視時間。此外，系統設計的模組化和以軟體為中心的升級方式，使得醫療機構能夠透過定期的功能增強來延長現有設備的使用壽命，而無需更換整個系統。

我們將評估累積關稅措施如何改變了我們整個醫療影像設備產品組合的供應鏈經濟、採購行為和策略採購決策。

美國於2025年實施的關稅措施的累積影響波及C型臂系統的整個供應鏈、採購慣例和定價策略。對醫療設備零件和成品徵收關稅增加了依賴國際製造和複雜全球採購的產品的採購成本。為此，製造商正在考慮一系列戰術性應對措施，包括將成本轉嫁給買家、暫時自行承擔部分利潤以維持競爭力，或審查供應商合約並更換關鍵零件的來源。

詳細的細分分析表明，臨床應用、最終用戶類型、行動性差異和銷售管道如何共同決定差異化的商業性方法。

了解市場區隔對於制定有針對性的商業策略和產品藍圖至關重要。根據應用領域，臨床需求多種多樣，例如，心血管手術需要介入心臟病學和血管外科中獨特的成像人體工程學和透視功能；牙科手術具有獨特的成像幾何結構；胃腸病學手術優先考慮與內鏡工作流程的兼容性；神經外科、關節重組、脊柱手術和創傷手術對精度和圖像融合要求極高，每種劑量泌尿系統都需要不同的視野和手術手術也將定位不同的手術

區域市場動態和策略重點決定了產品設計選擇、監管應對措施以及在全球醫療保健生態系統中的服務部署。

區域趨勢對產品設計、監管策略和市場拓展計畫有顯著影響。在美洲，醫療系統優先考慮整合式診療路徑、先進的影像技術和完善的售後服務網路。同時，健保報銷環境以及公立和私立醫院的結構也影響著採購週期和資金籌措偏好。因此，供應商優先考慮的是完善的服務部署、臨床證據的累積以及與關鍵醫療中心的合作，以加速產品部署。

為什麼技術創新、廣泛的服務生態系統和策略性經銷夥伴決定了競爭優勢和商業性發展動能？

C型臂領域的競爭動態仍有利於那些兼具技術領先地位、廣泛服務網路和靈活經營模式的公司。業界領導企業透過提供支援高級引導、直覺式使用者介面和強大劑量管理的整合式成像平台脫穎而出。持續投資於軟體更新和模組化硬體選項的公司，透過實現無需系統全面更換即可逐步增強功能，從而加強了與客戶的關係。同時，擁有良好業績記錄的公司能夠提供符合醫院營運目標的遠距離診斷，並具備快速部署、預防性保養計劃和最大限度減少停機時間的優勢。

為高階主管提供的實用指南，內容涵蓋如何增強產品韌性、實現供應鏈多元化、提高商業性柔軟性以及加速臨床部署。

產業領導者若想將不斷變化的需求模式轉化為商機，應採取一系列切實可行的優先事項，以平衡短期韌性和長期差異化優勢。首先，調整產品藍圖，以滿足多樣化的用戶需求，同時透過優先考慮模組化、軟體可升級性和劑量最佳化功能來實現規模經濟，這些功能預計將在多個臨床專科領域中廣泛應用。其次，透過多元化組件採購和實施短期緊急應變計畫來增強供應鏈韌性。同時，考慮對關鍵子系統進行選擇性近岸外包，以降低關稅風險和前置作業時間波動的影響。

採用嚴謹的混合方法，結合臨床醫生的見解、採購情報、技術基準測試和諮詢檢驗，確保獲得可操作的見解。

本分析的調查方法結合了定性和定量方法，以確保得出嚴謹且切實可行的見解。主要研究工作包括對具有代表性的群體進行深度訪談，這些群體包括臨床負責人、採購負責人和行業高管，旨在收集有關採購標準、營運限制和未滿足的臨床需求的第一手資訊。這些一手資訊與來自監管文件、臨床文獻、醫療設備使用說明書和公共採購記錄的二手資訊相結合，以檢驗觀察到的趨勢，並從多個角度協調相關人員的觀點。

整合市場動態，展現技術優勢、供應鏈敏捷性和以客戶為中心的服務模式如何創造永續的競爭優勢。

總之，由於技術進步、醫療服務模式的變革以及採購壓力的增加，C型臂市場正處於轉折點。那些投資於模組化、以軟體為中心的平台、強化服務和分銷網路並展現出清晰的臨床和經濟價值的供應商，將更有利於把握各種臨床應用和區域市場的機會。同時，關稅和供應鏈中斷等外部因素進一步凸顯了策略採購和靈活商業性提案的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依移動性分類的固定式和可攜式C型臂市場

  • 固定的
  • 活動

第9章 固定式和可攜式C型臂市場：按應用領域分類

  • 心血管外科
    • 介入性心臟病學
    • 血管外科
  • 牙科手術
  • 胃腸病學
  • 神經外科
  • 整形外科
    • 關節重組
    • 脊椎手術
    • 創傷外科
  • 泌尿系統

第10章 固定式和可攜式C型臂市場：按最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院
    • 私立醫院
    • 公立醫院

第11章 固定式和可攜式C型臂市場：依銷售管道分類

  • 離線
  • 線上

第12章 固定式和可攜式C型臂市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 固定式與可攜式C臂市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 固定式和可攜式C型臂市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國固定式和可攜式C型臂市場

第16章：中國固定式與可攜式C臂市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agfa-Gevaert Group（Agfa Healthcare）
  • Allengers Medical Systems
  • BPL Medical Technologies
  • Canon Medical Systems Corporation
  • Carestream Health
  • DMS Imaging（DMS Group）
  • Eurocolumbus Srl
  • FUJIFILM Holdings Corporation
  • GE HealthCare
  • Genoray Co. Ltd.
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Medtronic
  • OrthoScan, Inc.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Skanray Technologies
  • SternMed GmbH
  • Trivitron Healthcare
  • Ziehm Imaging GmbH
Product Code: MRR-742BD517E39C

The Fixed & Mobile C-arms Market was valued at USD 2.92 billion in 2025 and is projected to grow to USD 3.12 billion in 2026, with a CAGR of 6.07%, reaching USD 4.42 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.92 billion
Estimated Year [2026] USD 3.12 billion
Forecast Year [2032] USD 4.42 billion
CAGR (%) 6.07%

A comprehensive framing of how imaging performance, mobility profiles, and interoperability requirements are redefining clinical procurement and adoption choices

Fixed and mobile C-arm systems remain central to modern procedural medicine, enabling real-time imaging across a broad set of surgical and interventional disciplines. The introduction frames the market through the lens of technological integration, care-site diversification, and shifting procurement behaviors. As health systems prioritize minimally invasive procedures, image-guidance platforms become integral to clinical pathways, leading clinicians and purchasing committees to evaluate C-arm performance across resolution, dose management, workflow integration, and ease of use.

Moreover, the introduction contextualizes how different mobility profiles-fixed installations for hybrid operating rooms and mobile units for procedure suites and ambulatory settings-respond to distinct clinical and operational requirements. Interoperability with electronic health records, compatibility with advanced imaging and navigation systems, and support for remote diagnostic workflows have risen in importance. Consequently, stakeholders are balancing capital allocation with operational considerations such as maintenance contracts, uptime guarantees, and staff training.

Transitioning from clinical utility to market dynamics, the intro highlights the convergence of clinical demand and supplier innovation. Regulatory expectations, heightened focus on patient safety, and a growing emphasis on radiation dose reduction are shaping procurement criteria. In sum, this opening sets an evidence-based stage for more detailed analysis of structural shifts, policy impacts, and segmentation-driven strategies that follow in the subsequent sections.

How advances in AI-driven imaging, modular design, and care-site migration are reshaping procurement priorities and competitive positioning for C-arm systems

The landscape for C-arm systems is undergoing transformative shifts driven by technological advances, evolving clinical pathways, and structural changes in care delivery. Artificial intelligence and enhanced image processing algorithms are improving intraoperative visualization, enabling clinicians to operate with greater precision while potentially reducing fluoroscopy time. Furthermore, modularity in system design and software-centric upgrades allow providers to extend the useful life of installed equipment through periodic feature enhancements rather than full system replacements.

At the same time, care is migrating out of traditional inpatient settings into ambulatory surgical centers and specialty clinics, prompting demand for compact mobile units that balance image quality with portability. As a result, manufacturers are tuning product lines to support a broader range of clinical environments, emphasizing rapid setup, small footprints, and simplified user interfaces. Payment models and procurement strategies are also shifting; hospitals and clinics increasingly evaluate total cost of ownership, vendor service networks, and financing options, which impacts adoption timelines and replacement cycles.

Supply chain resilience is another major element reshaping the market. Manufacturers are pursuing diversified sourcing, near-shoring of critical components, and closer vendor collaboration to mitigate disruptions. In parallel, regulatory scrutiny around device interoperability, cybersecurity, and radiation safety has intensified, encouraging suppliers to embed compliance and security-by-design principles into their development roadmaps. Taken together, these forces are producing a more competitive, innovation-driven environment where clinical value, operational flexibility, and strategic supply continuity determine market leadership.

Evaluating how cumulative tariff measures have altered supply chain economics, procurement behavior, and strategic sourcing decisions across imaging equipment portfolios

The cumulative impact of tariff actions implemented by the United States in 2025 reverberates across the supply chain, procurement practices, and pricing strategies for C-arm systems. Tariffs on medical device components and finished units increase landed costs for products that rely on international manufacturing and complex global sourcing. In response, manufacturers evaluate a spectrum of tactical and strategic responses that include passing costs through to buyers, absorbing margins temporarily to retain competitive positioning, or restructuring supplier agreements to relocate critical component sourcing.

Operationally, hospitals and ambulatory centers confront heightened budgetary scrutiny as procurement committees reassess capital projects in light of increased acquisition costs. Consequently, capital planning cycles may lengthen and vendors may be required to provide more flexible financing, extended service agreements, or bundled consumable offerings to preserve procurement momentum. Additionally, higher import costs can accelerate conversations around localization and near-shoring; however, shifting production footprints entails lead times and capital investment that temper immediate migration.

From a strategic perspective, tariffs also provoke renewed emphasis on value engineering and product differentiation. Vendors are incentivized to develop offerings that emphasize lifecycle cost reductions through lower maintenance requirements, software-driven functionality upgrades, and energy efficiency. Meanwhile, health systems may seek multi-supplier strategies and framework agreements to distribute procurement risk. Ultimately, the 2025 tariff landscape makes supply chain transparency, contractual flexibility, and demonstrated total cost benefits decisive factors in commercial negotiations.

Deep segmentation intelligence showing how clinical applications, end-user types, mobility distinctions, and sales channels jointly define differentiated commercial approaches

Understanding segmentation is essential for crafting targeted commercial strategies and product roadmaps. Based on application, clinical demand spans specialties such as cardiovascular surgery, where interventional cardiology and vascular surgery require distinct imaging ergonomics and fluoroscopic performance, dental surgery with its specific imaging geometries, gastroenterology procedures that prioritize compatibility with endoscopic workflows, neurosurgery where precision and image fusion capabilities are paramount, orthopedic surgery which includes joint reconstruction, spinal surgery, and trauma surgery each with differing field-of-view and imaging mobility requirements, and urology where flexible positioning and dose management influence buying criteria.

Based on end user, purchasing behaviors and operating constraints vary between ambulatory surgical centers, clinics, and hospitals, with hospitals themselves representing private and public institutions that follow different procurement protocols, budget cycles, and regulatory oversight. These distinctions influence not only the preferred mobility solutions but also the level of service support and uptime commitments required. Based on mobility, the market differentiates fixed systems-typically installed in hybrid ORs and optimized for high-end surgical suites-from mobile units that support procedure rooms, outreach clinics, and point-of-care imaging needs, each driving unique installation and workflow considerations.

Finally, based on sales channel, engagement strategies differ between direct sales models and distributor-led approaches. Direct sales often facilitate deeper clinical relationships and bundled contracting, whereas distributor channels, which encompass e-commerce and value-added resellers, extend geographic reach and provide local logistics, installation, and service capabilities. Synthesizing these segmentation lenses reveals that effective commercialization requires aligning product attributes, service models, and channel incentives with the specific clinical, operational, and procurement realities of each buyer cohort.

Regional market dynamics and strategic priorities that determine product design choices, regulatory pathways, and service footprints across global healthcare ecosystems

Regional dynamics exert distinct influences on product design, regulatory strategy, and go-to-market planning. In the Americas, health systems emphasize integrated care pathways, advanced imaging capabilities, and strong aftersales service networks, while reimbursement environments and private versus public hospital structures shape procurement cycles and financing preferences. Consequently, suppliers prioritize robust service footprints, clinical evidence generation, and partnerships with leading medical centers to accelerate adoption.

Across Europe, Middle East & Africa, the regulatory mosaic and diverse payer structures require adaptive strategies that balance centralized approvals with country-level market access planning. Procurement practices in these regions may favor public tendering and consortium purchasing in certain markets, which elevates the importance of competitively priced, reliable systems and cost-of-ownership narratives. Meanwhile, the Middle Eastern markets often show accelerated capital investment in advanced hybrid ORs, creating opportunities for fixed systems paired with comprehensive service contracts. In Africa, infrastructure constraints can increase demand for rugged, energy-efficient mobile solutions.

In the Asia-Pacific region, rapid expansion of ambulatory services, rising procedure volumes, and substantial investments in hospital modernization drive demand across both fixed and mobile categories. Diverse maturity levels among healthcare markets mean suppliers must offer a spectrum of solutions, from premium integrated systems for advanced medical centers to cost-effective, high-value units tailored for emerging markets. Across all regions, successful market entry depends on localized clinical education, regulatory alignment, and distribution partnerships that reflect regional operational realities.

Why technological innovation, expansive service ecosystems, and strategic distribution partnerships will determine competitive advantage and commercial momentum

Competitive dynamics in the C-arm space continue to favor companies that combine technological leadership with expansive service networks and flexible commercial models. Leaders differentiate by offering integrated imaging platforms that support advanced guidance, intuitive user interfaces, and robust dose management. Firms investing in continuous software updates and modular hardware options create stickiness with customers by enabling incremental capability enhancements without full-system replacement. At the same time, companies with deep installation footprints can deliver rapid deployment, preventive maintenance programs, and remote diagnostics that minimize downtime and align with hospital operational goals.

Additionally, strategic partnerships and alliances-both with clinical centers and with software or navigation providers-are shaping competitive advantage. Organizations that cultivate clinical evidence through peer-reviewed studies and real-world use cases strengthen buyer confidence and accelerate adoption in specialized procedures. Distribution strategy also remains a differentiator: direct sales channels offer closer clinical engagement and value-based contracting, whereas distributor networks expand reach in regions where local logistics and service capability are paramount.

Finally, smaller innovative firms continue to influence the market by introducing niche technologies, such as compact mobile units optimized for ambulatory settings or AI-enabled reconstruction techniques that enhance image clarity. These entrants force incumbents to respond through targeted product enhancements, strategic acquisitions, or reshaped pricing models. The net effect is a market where technological differentiation, service quality, and channel strategy determine competitive positioning and commercial traction.

A practical playbook for executives to strengthen product resilience, diversify supply chains, expand commercial flexibility, and accelerate clinical adoption

Industry leaders seeking to capitalize on shifting demand patterns should adopt a set of actionable priorities that balance short-term resilience with long-term differentiation. First, align product roadmaps to prioritize modularity, software-upgradability, and dose optimization features that resonate across multiple clinical specialties, thereby achieving economies of scale while addressing diverse user needs. Next, strengthen supply chain resilience by diversifying component sourcing and implementing near-term contingency plans; at the same time, evaluate selective near-shoring for critical subsystems to reduce tariff exposure and lead-time volatility.

Simultaneously, refine commercial models by offering financing options, performance-based warranties, and bundled service agreements that ease capital constraints and emphasize total lifecycle value. Invest in outcomes-focused clinical studies and targeted training programs to accelerate clinician adoption and demonstrate measurable improvements in workflow efficiency and patient safety. Expand channel flexibility by combining direct sales expertise with selective distributor partnerships, including e-commerce and value-added resellers where appropriate, to broaden geographic reach without diluting clinical support quality.

Lastly, embed regulatory and cybersecurity considerations early into product development to reduce time-to-market risk and differentiate on compliance. By executing these recommendations in a coordinated manner, leaders can create defensible positions that mitigate near-term external pressures while building capabilities that translate into sustained commercial growth.

A rigorous mixed-methods approach combining clinician insights, procurement intelligence, technical benchmarking, and advisory validation to ensure actionable findings

The research methodology underpinning this analysis combines qualitative and quantitative approaches to ensure rigorous, actionable findings. Primary research involved in-depth interviews with a representative cross-section of clinical leaders, procurement officers, and industry executives to capture firsthand insights into buying criteria, operational constraints, and unmet clinical needs. These primary inputs were synthesized with secondary intelligence drawn from regulatory filings, clinical literature, device instructions for use, and public procurement records to validate observed trends and triangulate stakeholder perspectives.

Analytical techniques included comparative feature benchmarking across device classes, assessment of service and maintenance models, and scenario analysis to explore the implications of policy changes such as tariff adjustments. Where appropriate, supplier product portfolios were evaluated for modular upgrade pathways, interoperability features, and software support models. The methodology emphasized transparency in assumptions and traceability of sources, and each major conclusion is grounded in multiple lines of evidence.

Finally, findings were reviewed by an external advisory panel of clinicians and procurement specialists to ensure clinical relevance and practical applicability. This mixed-methods approach delivers balanced insights that are both strategically meaningful for executives and operationally actionable for commercial teams.

A synthesis of market dynamics showing how technical excellence, supply chain agility, and customer-focused service models create sustainable competitive advantage

In conclusion, the C-arm market is at an inflection point driven by technological advancement, changing care delivery models, and evolving procurement pressures. Suppliers that invest in modular, software-centric platforms, strengthen their service and distribution footprints, and demonstrate clear clinical and economic value will be best positioned to capture opportunities across a diverse set of clinical applications and regional markets. Meanwhile, external factors such as tariff actions and supply chain disruptions have heightened the importance of strategic sourcing and flexible commercial offerings.

Looking ahead, successful organizations will integrate clinical evidence generation with adaptive commercial models that reflect localized payer and institutional dynamics. By doing so, they can reduce adoption friction, shorten procurement cycles, and create deeper customer relationships that extend beyond initial equipment sales. Collaboration across industry partners, health systems, and regulatory bodies will also be essential to advance interoperability, safety, and clinician training. Overall, the market rewards those who combine technical excellence with operational agility and customer-centric service models.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Fixed & Mobile C-arms Market, by Mobility

  • 8.1. Fixed
  • 8.2. Mobile

9. Fixed & Mobile C-arms Market, by Application

  • 9.1. Cardiovascular Surgery
    • 9.1.1. Interventional Cardiology
    • 9.1.2. Vascular Surgery
  • 9.2. Dental Surgery
  • 9.3. Gastroenterology
  • 9.4. Neurosurgery
  • 9.5. Orthopedic Surgery
    • 9.5.1. Joint Reconstruction
    • 9.5.2. Spinal Surgery
    • 9.5.3. Trauma Surgery
  • 9.6. Urology

10. Fixed & Mobile C-arms Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals
    • 10.3.1. Private Hospitals
    • 10.3.2. Public Hospitals

11. Fixed & Mobile C-arms Market, by Sales Channel

  • 11.1. Offline
  • 11.2. Online

12. Fixed & Mobile C-arms Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Fixed & Mobile C-arms Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Fixed & Mobile C-arms Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Fixed & Mobile C-arms Market

16. China Fixed & Mobile C-arms Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agfa-Gevaert Group (Agfa Healthcare)
  • 17.6. Allengers Medical Systems
  • 17.7. BPL Medical Technologies
  • 17.8. Canon Medical Systems Corporation
  • 17.9. Carestream Health
  • 17.10. DMS Imaging (DMS Group)
  • 17.11. Eurocolumbus Srl
  • 17.12. FUJIFILM Holdings Corporation
  • 17.13. GE HealthCare
  • 17.14. Genoray Co. Ltd.
  • 17.15. Hologic, Inc.
  • 17.16. Koninklijke Philips N.V.
  • 17.17. Medtronic
  • 17.18. OrthoScan, Inc.
  • 17.19. Shimadzu Corporation
  • 17.20. Siemens Healthineers
  • 17.21. Skanray Technologies
  • 17.22. SternMed GmbH
  • 17.23. Trivitron Healthcare
  • 17.24. Ziehm Imaging GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FIXED & MOBILE C-ARMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FIXED & MOBILE C-ARMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY FIXED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY FIXED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY VASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY VASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY DENTAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY DENTAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY DENTAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY JOINT RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY JOINT RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY SPINAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY SPINAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY TRAUMA SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY TRAUMA SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY TRAUMA SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS FIXED & MOBILE C-ARMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. GCC FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 145. GCC FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. GCC FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 148. GCC FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. GCC FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 150. GCC FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. G7 FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 169. G7 FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. G7 FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 172. G7 FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. G7 FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 174. G7 FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. NATO FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 177. NATO FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. NATO FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 180. NATO FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. NATO FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 182. NATO FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)